You are here: Industry Insights > COVID-19

News List

US DOJ permits six drug makers to share info about COVID-19 MAb treatments to expedite production expresspharma
July 27, 2020
The approval granted through a business review letter from the Justice Department's antitrust division, however, has not allowed any discussion on the pricing of the treatments and production costs.
Researchers identify 21 existing drugs that block coronavirus in lab studies expresspharma
July 27, 2020
The study said that four of these compounds could work in combination with remdesivir, a current standard-of-care treatment for COVID-19.
Scientists decode how coronavirus molecules camouflage in host cell expresspharma
July 27, 2020
According to the researchers, this development may pave the way for the design of new drugs against the novel coronavirus SARS-CoV-2, and other emerging coronavirus infections.
New data shows steep rise in people waiting for cancer tests pharmatimes
July 24, 2020
Alarm bells are ringing again over the impact of the COVID-19 pandemic on cancer care in the UK, after Cancer Research UK unveiled new data showing a steep rise in the number of people waiting for diagnostic tests, and a study published in ...
COVID-19 more severe in colder months, research suggests pharmatimes
July 24, 2020
Environmental temperature and humidity have an effect on the severity of COVID-19 symptoms, researchers from Europe and China have concluded.
Novartis Launches Not-for-Profit Portfolio for Symptomatic Treatment of COVID-19 americanpharmaceuticalreview
July 24, 2020
Novartis announced a new initiative to help patients in low-income and lower-middle-income countries (LIC; LMIC) access affordable medicines to treat the major symptoms of COVID-19 – a critical need in the absence of a vaccine or curative treatment.
BioAegis Receives Approval to Proceed with Gelsolin Trial for COVID-19 americanpharmaceuticalreview
July 24, 2020
BioAegis Therapeutics announced it received regulatory clearance from The Spanish Agency for Medicines and Health Products (AEMPS) for its Phase 2 Proof of Concept study of its lead product, recombinant human plasma gelsolin (rhu-pGSN) in hospitalized ...
EMA to monitor real world use of COVID-19 treatments and vaccines europeanpharmaceuticalreview
July 24, 2020
The EMA has built up an infrastructure to allow for the monitoring of COVID-19 treatments and vaccines used in clinical practice.
Researchers say newly identified antibodies can neutralise SARS-CoV-2 pharmaceutical-technology
July 24, 2020
Researchers at Columbia University Irving Medical Center in the US have identified neutralising antibodies, isolated from Covid-19 patients, against the SARS-CoV-2 virus.
Maha FDA files FIR against five people, guilty in blackmarketing of remedisivir and tocilizumab expresspharma
July 24, 2020
The team seized medicines worth Rs 3,13,482 for COVID-19 and other therapeutic categories.